Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-08

FDA Approved: DIMETHYL FUMARATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for dimethyl fumarate (ANDA 210305) by Cipla USA Inc., enabling the continued market availability of a generic version o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dimethyl fumarate (generic) (Dimethyl fumarate)
  • Tecfidera (dimethyl fumarate)

Snippet

SUPPL AP for DIMETHYL FUMARATE (DIMETHYL FUMARATE)